Category Archives: Biotechnology

Polymerase Chain Reaction (PCR) Sales to Surpass US$ 12 Bn through 2031 as Adoption of Real-Time PCR Surges amid COVID-19

Fact.MRs latest study discusses factors affecting the polymerase chain reaction (PCR) market growth. It provides in-depth analysis of various market segments, including product and end user across seven major regions. The report further profiles leading PCR manufacturers and examines the effect of their growth strategies on the global market.

Fact.MR A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global polymerase chain reaction (PCR) market will reach US$ 3.6 Bn by the end of 2021. Owing to the surging demand for PCR products, the overall market is projected to register growth at 10% CAGR between 2021 and 2031.

Sales in the PCR market are expected to increase with rising prevalence of target diseases and genetic disorders. Also, factors such as growing popularity of portable PCR testing kits, advancements in PCR technology, and increasing government funding for research activities will facilitate the growth in the market.

PCR has emerged as an ideal technique for the amplification of DNA sequences. It is a simple and cost-effective technique which produces results rapidly. It is an extensively used technique in medical laboratory research for a wide range of applications including biomedical research and criminal forensics.

The unprecedented outbreak of COVID-19 had a positive impact on the PCR market. It created huge demand for reliable and rapid detection techniques such as RT-PCR. Various companies also launched novel PCR test kits for the detection of virus.

Also, RT-PCR emerged as an ideal technique for detection of COVID-19 virus. It is significantly faster and has lower risk of contamination or errors.

Request a report sample to gain compressive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=4861

As per Fact.MR analysis, PCR reagents will account for around 60% of total PCR market revenue by 2031. Rising demand for diagnostic tests and launch of new reagents specific to the test type are some key factors accelerating the demand for reagents used in polymerase chain reaction. Furthermore, RT PCR systems market to witness significant growth.

Regionally, North America will continue to dominate the PCR market, owing to the presence of a well-established healthcare infrastructure, continuous advances in clinical research, and high prevalence of genetic disorders such as Klinefelter's syndrome and Down syndrome. The region is poised to expand at a healthy growth rate of 7.5% annually.

However, Asia is projected to register the fastest growth on the back of increasing penetration of PCR products, rising government support, high prevalence of chronic diseases, and expanding healthcare infrastructure.

As the demand for PCR continues to rise, leading manufacturers are moving towards developing portable micro-scale devices. They also are introducing advanced PCR instruments, reagents and consumable that will allow quick nucleic acid amplification. This is expected to create growth opportunities for the market, says a Fact.MR analyst

Key Takeaways from Polymerase Chain Reaction Market Survey

Key Drivers

Key Restraints

To gain in-depth insights on Polymerase Chain Reaction Market, request methodology at

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4861

Competitive Landscape

Key players operating in the polymerase chain reaction market are embracing advanced technologies for the development of new products. They have adopted various strategies such as mergers, partnerships, collaborations and manufacturing of advanced portable PCR products to increase their sales.

Some of the prominent players operating in the polymerase chain reaction market profiled by Fact.MR are:

More Insights on the Global Polymerase Chain Reaction Sales Outlook

Fact.MR provides an incisive coverage on global polymerase chain reaction market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global demand for polymerase chain reaction with a detailed segmentation on the basis of:

Key Questions Covered in the Polymerase Chain Reaction Market Outlook Report

Explore Fact.MRs Coverage on the Healthcare Domain

Rapid Medical Diagnostic Kits Market- Infectious disease incidence has been steadily increasing over the last few decades, driving up demand for rapid medical diagnostic kits around the world. The need to detect novel pathogens that cause diseases is propelling the market forward. The low cost of rapid medical diagnostic kits is propelling market growth. Blood glucose testing is in high demand, and it has been growing at the quickest rate of all types of tests across all geographies. Technology advancements and strategic alliances by key market players have paved the way for rapid medical diagnostic kit innovations.

COVID-19 Saliva-based Detection Kits- COVID-19 detection treatments are likely to be in high demand due to the availability of COVID-19 virus variants and the continued danger of infection. Manufacturers are focusing on delivering cost-effective and convenient testing solutions as COVID-19 diagnostics become more widely employed. While vaccination initiatives have reduced the incidence rate in some nations, the virus continues to represent a serious concern and has a high occurrence rate due to mutant forms. Future viral mutant strains, as well as increased knowledge of COVID-19 testing, are predicted to maintain market growth.

PCR and Real-time PCR Molecular Diagnostics Market - The COVID-19 pandemic has boosted prospects for the growth of the PCR and real-time PCR molecular diagnostics market. Real-time (qPCR) and digital (dPCR) PCR tests have been used in a variety of healthcare settings to detect and diagnose potential cases. Because of its high sensitivity, healthcare providers have embraced PCR tests on a large scale. As a result of such trends, the global PCR and real-time PCR molecular diagnostics market is poised to soar to new heights, surpassing a significant revenue threshold in the coming decade.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.

MarketNgage is powered by Fact.MR our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.

You can access all our healthcare research reports by signing up with MarketNgagesMarket Research Subscriptionwith FREE credits. MarketNgage is powered by Fact.MR A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.

Contact:

Mahendra SinghUS Sales Office11140 Rockville PikeSuite 400Rockville, MD 20852United StatesTel: +1 (628) 251-1583E: sales@factmr.com

Source: Fact.MR

Go here to read the rest:
Polymerase Chain Reaction (PCR) Market to Expand by 3.3x as Application in Pharmaceutical & Biotechnology Industry Grows - BioSpace

Northampton, MA --News Direct-- Illumina

Were honored to be named to the prestigious 2021 Dow Jones Sustainability Indices for a third year in a row. Illumina received the highest score in the Pharmaceuticals, Biotechnology and Life Sciences industry.

Inclusion in the DJSI highlights our commitment to continuously improving and growing our Corporate Social Responsibility (CSR) program to build a more sustainable and equitable future for all. Our program focuses on accelerating access to genomics, supporting our communities, and integrating environmental stewardship into our operations.

If you would like to hear more about our CSR program, join us at our inaugural ESG Investor event on Tuesday Nov 16 at 11 am PT.

Thank you to all our employees for championing the needs of patients, customers, our communities, and our planet.

View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/illumina-named-to-2021-dow-jones-sustainability-indices-with-highest-score-in-pharmaceuticals-biotechnology-and-life-sciences-industry-107725996

See more here:
Illumina Named to 2021 Dow Jones Sustainability Indices With Highest Score in Pharmaceuticals, Biotechnology and Life Sciences Industry - Yahoo...

The report on Global Food Biotechnology Market has been provided by researchers for a detailed understanding of market performance over an estimated period of time set from 2021 to 2026. However, this report has introduced a brief overview to provide the reader with better information on this report. This brief description contains a basic definition of the product or service studied in the report. Along with this, it also contains a summary of the main applications of this product or service in various industrial sectors. In addition, market research experts have also provided information on the manufacture or production of the product or service and its distribution strategy.

Other important factors studied in the global Food Biotechnology market report include demand and supply dynamics, industrial processes, import and export scenarios, R&D development activities and cost structures. In addition, this report also calculates figures for demand and supply for consumption, production cost, gross profit margins and sales price for products.

Get FREE Sample copy of this Report with Graphs and Charts at:https://reportsglobe.com/download-sample/?rid=289972

The segmentation chapters enable readers to understand aspects of the market such as its products, available technology and applications. These chapters are written to describe their development over the years and the course they are likely to take in the coming years. The research report also provides detailed information on new trends that may define the development of these segments in the coming years.

Food Biotechnology Market Segmentation:

Food Biotechnology Market, By Application (2016-2027)

Food Biotechnology Market, By Product (2016-2027)

Major Players Operating in the Food Biotechnology Market:

Company Profiles This is a very important section of the report that contains accurate and detailed profiles for the major players in the global Food Biotechnology market. It provides information on the main business, markets, gross margin, revenue, price, production and other factors that define the market development of the players studied in the Food Biotechnology market report.

Global Food Biotechnology Market: Regional Segments

The different section on regional segmentation gives the regional aspects of the worldwide Food Biotechnology market. This chapter describes the regulatory structure that is likely to impact the complete market. It highlights the political landscape in the market and predicts its influence on the Food Biotechnology market globally.

Get up to 50% discount on this report at:https://reportsglobe.com/ask-for-discount/?rid=289972

The Study Objectives are:

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Food Biotechnology market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Some Major Points from Table of Contents:

Chapter 1. Research Methodology & Data Sources

Chapter 2. Executive Summary

Chapter 3. Food Biotechnology Market: Industry Analysis

Chapter 4. Food Biotechnology Market: Product Insights

Chapter 5. Food Biotechnology Market: Application Insights

Chapter 6. Food Biotechnology Market: Regional Insights

Chapter 7. Food Biotechnology Market: Competitive Landscape

Ask your queries regarding customization at: https://reportsglobe.com/need-customization/?rid=289972

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email: [emailprotected]

Website: Reportsglobe.com

Link:
Food Biotechnology Market 2021 Detailed Analysis of top Ventures with Regional Outlook | Key Companies: ABS Global, Arcadia Biosciences, AquaBounty...

Published: Oct. 25, 2021 at 8:30 AM CDT|Updated: 16 hours ago

SAN DIEGO, Oct. 25, 2021 /PRNewswire/ -- Neurophth Therapeutics Ltd.,("Neurophth") a fully-integrated genomic medicines company seekingto improve lives through the curative potential ofgene therapies, today announced that Qiutang Li, Ph. D., Neurophth's Chief Scientific Officer, has been listed as one of The Top 25 Women Leaders in Biotechnology of 2021 by The Healthcare Technology Report.

Neurophth congratulates its very own Dr. Qiutang Li as well as all the other award winners who have been recognized by The Healthcare Technology Report in their Top 25 Women Leaders in Biotechnology 2021. According to The Healthcare Technology Report, theseaccomplished women were selected based on hundreds of nominations and comprehensive analysis of professional milestones achieved, longevity in the biotech field and demonstrated domain expertise. They represent a diverse range of positions, specialties, and backgrounds.Formore information on The Healthcare Technology Report, please visit the official website at https://thehealthcaretechnologyreport.com/the-top-25-women-leaders-in-biotechnology-of-2021/.

"I amhumbled andhonoredto be included among this list of outstanding women leaders who are boldly changing the future of life science industry, " saidDr. Qiutang Li. "I share this distinction with all my Neurophth femalecolleagueswho come to work each day to share their expertise and insights as we follow the company'svision of 'buildinga brighter future for patients withinnovative gene therapies'and looking forward to leadtheteam into the successful development of the first China-manufactured AAV ocular gene therapy product globally."

"Congratulations to these exceptional women whose passion for creating medicines of value have led them to consistently achieve and thrive in our ever-evolving life sciences industry," said Dr. Alvin Luk, CEO of Neurophth. "Qiutang, a Chinese female scientist named Top 25 women leaders in Biotechnology of 2021, is an outstanding scientific leader who is leading all R&D efforts in both China and USA to take Neurophth's first product, NR082 for the treatment of ND4-mutated Leber hereditary optic neuropathy, from IND-enabling studies to clinical trial. She also works tirelessly to expand our portfolio pipeline from ocular to extra-ocular diseases".

Dr. Qiutang Li has over 30 years of experience in basic and applied biomedical research with extensive knowledge in gene therapy for hepatic deficiencies, ocular diseases, and viral vector reconstruction. She joins Neurophth from the University of Louisville School of Medicine, where she was a tenured professor in the Department of Ophthalmology and Visual Sciences for over 14 years. Throughout her career, Dr. Li has published more than 45 publications in peer-reviewed journals including IOVS, PNAS, Nature Review Immunology, and Science. Dr. Li earned both of her bachelor and master's degrees in Genetics from Peking University, China, and her doctoral degree in Molecular Cell Biology from Washington University, St. Louis.

About Neurophth

Neurophth is China's first gene therapy company for ophthalmic diseases. With subsidiaries in China (Wuhan, Shanghai and Suzhou) and US (San Diego, California), Neurophth, a fully integrated company, is striving to discover and develop genomic medicines for patients suffering from genetic diseases globally. Our validated AAV platform, which has been published in Nature - Scientific Reports, Ophthalmology, and EBioMedicine, has successfully delivered proof-of-concept investigator-initiated trials data of 198 subjects with investigational gene therapies in the retina. Our most advanced investigational candidate, NR082 (NFS-01 project, rAAV2-ND4), in development for the treatment ofND4-mediated LHON, has been granted orphan drug designation (ODD) by theU.S. FDA and its IND evaluating NR082 in a Phase 1/2/3 clinical trial has also been approved by the China NMPA in March 2021 with the first patient being dosed in June 2021. The pipeline also includesND1-mediated LHON, autosomal dominant optic atrophy, optic neuroprotection (e.g., glaucoma), vascular retinopathy (e.g., diabetic retinopathy), and five other preclinical candidates. Neurophth has initiated the scaling up in-house manufacturing process in single-use technologies to support future commercial demand at the Suzhou facilities. To learn more about us and our growing pipeline, visitwww.neurophth.com.

View original content to download multimedia:

SOURCE Neurophth Therapeutics, Inc.

The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.

Read this article:
Qiutang Li, Neurophth CSO, Named Top 25 Women Leaders in Biotechnology 2021 - KWCH

Enteric Diseases Laboratory Branch (EDLB) preparing samples for DNA fingerprinting

Recent advancements in biotechnology have immense potential to help address many global problems; climate change, an aging society, food security, energy security, and infectious diseases.

Biotechnology is not to be confused with the closely related field of biosciences. While biosciences refer to all the sciences that study and understand life, biology, and biological organisms, biotechnology refers to the application of the knowledge of biosciences and other technologies to develop tech and commercial products. Biotechnology is the application of innovation to biosciences in a bid to solve real-world medical problems.

Throw Artificial Intelligence into the mix and we suddenly have a really interesting pot of broth. Several AI trends have already proven beneficial to the development of biotechnology. Dr. Nathan S. Bryan, an inventor, biochemist and professor, who made a name for himself as an innovator and pioneer in nitric oxide drug discovery, commercialization, and molecular medicine, offers his insights on these contributions.

Bryan has always held a strong interest in science and medicine and the innovations surrounding it, as signified in his insistence on the commercialization of his nitric oxide discoveries amid strong criticism and even opposition amongst his peers.. His strong entrepreneurial spirit as an academic was strange to many but has led to dozens of patents and product technology that have now generated over half a billion dollars in sales worldwide and an enterprise value of all his companies at over one billion dollars.

He is optimistic that AI has great potential to revolutionize the biotechnology industry if handled right.

Over the last 3 decades we have made tremendous strides in scientific discoveries that have become very impactful in drug development, health, wellness, and beauty, says Bryan.

All this was done mainly without Artificial Intelligence, imagine what we can achieve if the various concerns are handled and we can utilize the great advantage of machine learning to the fullest? Historically it takes an average of 17 years for a new discovery to come to market.Utilizing AI, it can happen much faster.Its a game-changer if I ever saw one.

AI-Generated Comprehensive Protein Map

Earlier this year the biotechnology world was rocked by an announcement by DeepMind, a subsidiary of Googles parent company, Alphabet. DeepMinds claimed to create the most comprehensive map of proteins to date using artificial intelligence.

Every investigation so far suggests that this is exactly what they have done. Before this breakthrough, determining the structure of a protein could only be done by a series of expensive and time-consuming experiments. However, DeepMind showed that relying on Alphafold, its AI software, it could produce accurate predictions of a proteins structure.

This extended the list of protein structures available in the public domain from 180,000, to a whopping 350,000 and everything can be downloaded by scientists for free. Perhaps the most profound part of this is that the list included 98% of all human proteins, which is astounding for scientists and researchers.

Bryan seems certain that this is just the tip of the iceberg for what is attainable. In his own words;

I can now go to the internet and download the most comprehensive list of human proteins ever into a memory stick. Frankly, that is an unexpected deluge of data, that we still dont know how to process, it is like taking us 10 years ahead in research. Its impact will probably not be felt in how people are treated instantly, but in the long run, it would have saved us a lot of years, says Bryan.

He continues, It only goes to show you why a lot of us in the scientific community are excited about the positive possibilities of AI. This is just the tip of the iceberg.Knowing a proteins structure helps us understand its function and how to repair it if an enzyme becomes dysfunctional.Many diseases, including many caused by a deficiency of nitric oxide are due to dysfunctional enzymes.

Open Source AI Platforms

Health care data and other scientific data are an ever-expanding library. The data is often scattered and complicated to arrange in any meaningful way without intense laborious work.

Scientists around the world are researching AI programs that can automate data maintenance and analysis. AI opensource platforms have become the answer to this desire in many ways. Open source platforms like H2O.ai, and DeepMIB have emerged in the last few years to free lab assistants from repetitive tasks such as data entry and analysis.

Bryan expands on the value of AI-open source platforms;

Research is a bigger deal than most people understand. A lot of tasks are heavy and repetitive, yet they have to be done repeatedly with the utmost care because every research failure is a lot of money and energy down the drain. Most basic science discoveries never lead to any effective medicine or therapy because it fails to translate into humans.

Dr. Nathan S. Bryan

He continues, In the science of nitric oxide, which is a gas that when produced is gone in less than a second, it has been very difficult to develop safe and effective therapeutics. We were the first to develop a solid dose of the nitric oxide gas.

Using AI platforms, we can monitor in real time changes in important vital signs and symptoms after administration to demonstrate safety and efficacy. This is really important since nitric oxide cant be measured in clinical labs like cholesterol or Vitamin D. Artificial intelligence is also quicker and more accurate in the analysis of other critical informatics.With the strain of manual labor gone, scientists and healthcare providers alike can focus on innovation.

Intelligent Disease Detection And Diagnosis

A recent study published in the Journal of the National Cancer Institute showed that the use of deep learning has been seen to achieve a breast cancer detection accuracy comparable to an average breast radiologist.

At the end of the day, every scientific sector and indeed every sector in the diverse industries depend on data to run effectively. The ability to organize and classify data into forums and subforums and to predict purported implications is one of the greatest advantages of Artificial Intelligence.

AI and IoT-powered wearables and appliances are another powerful way innovators are using AI to gather health data, in such a way that such data can be used to predict anomalies and early-stage diseases. Loss of nitric oxide is recognized as one of the earliest events in the onset and progression of every major chronic disease. Recognizing this prior to onset of symptoms is key to stopping the progression of disease. This will revolutionize health care and the costs associated with treating patients with advanced disease.

The possibilities are seemingly endless. According to Google, In their latest research, a neural network can be trained to detect signs of lung cancer faster and easier than trained radiologists. Developers are also trying to develop robust AI-driven software that can spot signs of a certain disease accurately in medical images such as, X-rays, MRIs, and CT scans.

Bryan explains, If we can eliminate mistakes in our approach and process, the world would be better for it. This is what I consider the greatest value AI brings. The ability to cross-reference the data of a patient against all other patients with similar diseases and to point out a single disimilarity can be the difference between losing a life and saving it.

What Does The Future Hold?

A lot of things have been touted. If algorithms can process all the information about our health, lifestyle, and the environment we live in, they can give suggestions on what to do to course-correct or to live healthier and hence make us live longer.

AI systems can help us stay fit, it can lighten the workload for doctors, reduce the workload for researchers and simplify the decision-making process. Its greatest contribution would be the ability to understand the vast amounts of scientific data that we have garnered from millennia of study and treatment. It is truly an exciting road of possibilities if we clear all the hurdles.

Bryan explains it well when he says; If we can deal with obstacles like biased data, extreme commercialization of AI systems, there is no way this would not be the catalyst for explosive scientific discoveries and more importantly translation of these discoveries into safe and effective therapeutics in this decade and beyond

As AI makes its journey from the periphery of sciences and healthcare to the mainstream, it seems that all we can do is marvel at the evolution and stand guard as well so that it doesn't become a double edged sword.

Link:
Artificial Intelligence Is Transforming Biotechnology, Especially When It Comes To Innovations In Nitric Oxide - Forbes

One of the issues that attracted agreement at the conference was the need to unite efforts regarding the dissemination of the benefits of plant biotechnology and the improvement of the regulatory aspects of its use in our country.

Science is a great ally in reaching agreements on possible ways to combat the effects of climate change. phrase from Carolina UrmenitaAnd Head of the Climate Change Office at the Ministry of Environment, summarizes the consensus among the speakers and speakers at the symposium Science, Agriculture and Climate Crisis, regarding the role that appropriate dissemination and linkage by the scientific world can play, to inform authorities, decision-makers and public opinion in general, of the potential that biotechnology can have, in the context of plant genetic improvement, as one of the options for addressing the challenges posed by climate change to agriculture Today.

Greetings from Alvaro Izaguirre, Executive Director of the Foundation for Agricultural Innovation, FIA, of the Ministry of AgricultureInitiated a symposium organized by ChileBio in which prominent national and international scholars and publishers participated, demonstrating various advances in Biotechnology for better food. Eyzaguirre commented: Science and agriculture must work together to make it more effective. This discipline plant biotechnology can be a strategic ally in the production of staple foods, commented. It is important for scientific communication to raise debate about the benefits of using these tools, especially when climate change is showing its effects, he added.

In this international symposium, the participation of the famous and famous scientist came to the fore. Jos Miguel Mollet, Chemistry Graduate and Ph.D. in Biochemistry and Molecular Biology from the University of ValenciaProfessor, Department of Biotechnology at the Polytechnic University of Valencia. He published a series of books and several articles in the press. He also highlighted the post Gabriel LyonAnd Chilean scientist, biochemist and physician in cell and molecular biology. A science communicator and author of popular science books such as Pop Science, What are snot? And Other Weird Questions I Sometimes Ask, among others.

Subsequently, a panel discussion was developed to which he joined Carolina Urmenita, Head of Climate Change Office at the Ministry of Environment and Francesca Castillo, Academician at Austral University in Chile and member of Agrupacin por la Biotecnologa y la Sostenibilidad Agroalimentaria (ABSA Chile), An exciting exchange of ideas, reflections and experiences on the role of plant biotechnology has developed.

Speakers have commented extensively on the difficulty of getting the message across from science that turns to evidence, in a world where emotion and shock seem to have more access to public opinion. Besides, they stressed the need for progress in Chile in organizing that allows us to use developments in the genetic improvement of vegetables in our cultivation, and to reach commercial stages, where today there is still an important crossroads.

CEO of ChileBIOAnd Miguel Angel Sanchez, He commented on the outcome of this meeting: It was a symposium that addressed the topics necessary to understand, discuss and look to the future regarding plant biotechnology. Both of them are of the necessity of communicating about the role of the various tools they possess, through misinformation and ignorance of their benefits. Climate change is here to stay, and the challenge of food production will increase to pursue Food security pathway. The development of plant varieties that are better adapted to climatic challenges, such as drought and heat tolerance and resistance to certain pests and diseases is a reality in the scientific world, he says.

One of the issues that attracted agreement at the conference was the need to unite efforts regarding the dissemination of the benefits of plant biotechnology and the improvement of the regulatory aspects of its use in our country. Sanchez concludes, There is a consensus in the scientific world about all the attributes of the different tools that biotechnology gives us, but there is an opinion of the public that views them with suspicion.. Gabriel Leon added: There is a schizophrenia between science and public opinion and this feeling has a very big impact.

Committee members agreed on the regulatory aspects that Chile needed to resolve in order for biotechnology solutions to be available for local production. On his part, he commented, Valuing biotechnology and making it available to small farmers is a viable path, in addition to creating an institutional framework that supports it. Dr. Francesca Castillo, researcher at the University of Austral and a spokesperson for the Association for Biotechnology and Food Sustainability (ABSA-Chile) who also stressed that there has to be a political will to sit down and discuss biotechnology, because its not all about genetics.

Read more from the original source:
A symposium entitled "Science, Agriculture and Climate Crisis", which highlighted the role of plant biotechnology in adapting agriculture to...